- Home
- ACIU vs FNKO Comparison
ACIU vs FNKO Comparison
Compare ACIU & FNKO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACIU
- FNKO
- Stock Information
- Founded
- ACIU 2003
- FNKO 2017
- Country
- ACIU Switzerland
- FNKO United States
- Employees
- ACIU N/A
- FNKO N/A
- Industry
- ACIU Biotechnology: Pharmaceutical Preparations
- FNKO Recreational Games/Products/Toys
- Sector
- ACIU Health Care
- FNKO Consumer Discretionary
- Exchange
- ACIU Nasdaq
- FNKO Nasdaq
- Market Cap
- ACIU 189.1M
- FNKO 225.8M
- IPO Year
- ACIU 2016
- FNKO 2017
- Fundamental
- Price
- ACIU $2.02
- FNKO $4.75
- Analyst Decision
- ACIU Strong Buy
- FNKO Buy
- Analyst Count
- ACIU 1
- FNKO 4
- Target Price
- ACIU $12.00
- FNKO $9.88
- AVG Volume (30 Days)
- ACIU 128.8K
- FNKO 1.1M
- Earning Date
- ACIU 08-05-2025
- FNKO 08-07-2025
- Dividend Yield
- ACIU N/A
- FNKO N/A
- EPS Growth
- ACIU N/A
- FNKO N/A
- EPS
- ACIU N/A
- FNKO N/A
- Revenue
- ACIU $32,014,254.00
- FNKO $1,024,890,000.00
- Revenue This Year
- ACIU N/A
- FNKO N/A
- Revenue Next Year
- ACIU $533.21
- FNKO $9.22
- P/E Ratio
- ACIU N/A
- FNKO N/A
- Revenue Growth
- ACIU 91.20
- FNKO N/A
- 52 Week Low
- ACIU $1.43
- FNKO $3.50
- 52 Week High
- ACIU $4.26
- FNKO $14.65
- Technical
- Relative Strength Index (RSI)
- ACIU 57.93
- FNKO 50.18
- Support Level
- ACIU $2.01
- FNKO $4.65
- Resistance Level
- ACIU $2.19
- FNKO $5.17
- Average True Range (ATR)
- ACIU 0.14
- FNKO 0.31
- MACD
- ACIU 0.00
- FNKO 0.00
- Stochastic Oscillator
- ACIU 60.75
- FNKO 18.92
About ACIU AC Immune SA
AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The Company has one segment. The Company currently focuses most of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.
About FNKO Funko Inc.
Funko Inc is an us-based pop culture consumer products company. It creates whimsical, fun, and different products that enable the customer to express their affinity for their favorite through the movie, TV show, video game, musician, or sports team. The company's current products are principally figures, fashion accessories, apparel, plush products, accessories, homewares, and NFTs. The company sells its products through a diverse network of retail customers across multiple retail channels, including specialty retailers, mass-market retailers, and e-commerce sites. The company generates the majority of its revenue from the core collectibles products.